Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Aug;59(2):417–422.

Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.

R Shimkets 1, M R Gailani 1, V M Siu 1, T Yang-Feng 1, C L Pressman 1, S Levanat 1, A Goldstein 1, M Dean 1, A E Bale 1
PMCID: PMC1914731  PMID: 8755929

Abstract

Gorlin syndrome is an autosomal dominant disorder characterized by multiple basal cell carcinomas, medulloblastomas, ovarian fibromas, and a variety of developmental defects. All affected individuals share certain key features, but there is significant phenotypic variability within and among kindreds with respect to malformations. The gene (NBCCS) maps to chromosome 9q22, and allelic loss at this location is common in tumors from Gorlin syndrome patients. Two recessive cancer-predisposition syndromes, xeroderma pigmentosum group A (XPAC) and Fanconi anemia group C (FACC), map to the NBCCS region; and unusual, dominant mutations in these genes have been proposed as the cause of Gorlin syndrome. This study presents cytogenetic and molecular characterization of germ-line deletions in one patient with a chromosome 9q22 deletion and in a second patient with a deletion of 9q22-q3l. Both have typical features of Gorlin syndrome plus additional findings, including mental retardation, conductive hearing loss, and failure to thrive. That Gorlin syndrome can be caused by null mutations (deletions) rather than by activating mutations has several implications. First, in conjunction with previous analyses of allelic loss in tumors, this study provides evidence that associated neoplasms arise with homozygous inactivation of the gene. In addition, dominant mutations of the XPAC and FACC1 genes can be ruled out as the cause of Gorlin syndrome, since the two patients described have null mutations. Finally, phenotypic features that show variable expression must be influenced by genetic background, epigenetic effects, somatic mutations, or environmental factors, since these two patients with identical alterations (deletions) of the Gorlin syndrome gene have somewhat different manifestations of Gorlin syndrome.

Full text

PDF
417

Images in this article

419Figure 1
on p.419
419Figure 2
on p.419
419Figure 3
on p.419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. E., Taylor W. B., Falls H. F., Davidson R. T. The nevoid basal cell carcinoma syndrome. Am J Hum Genet. 1967 Jan;19(1):12–22. [PMC free article] [PubMed] [Google Scholar]
  2. Bale A. E., Gailani M. R., Leffell D. J. Nevoid basal cell carcinoma syndrome. J Invest Dermatol. 1994 Nov;103(5 Suppl):126S–130S. doi: 10.1111/1523-1747.ep12399438. [DOI] [PubMed] [Google Scholar]
  3. Bialer M. G., Gailani M. R., McLaughlin J. A., Petrikovsky B., Bale A. E. Prenatal diagnosis of Gorlin syndrome. Lancet. 1994 Aug 13;344(8920):477–477. doi: 10.1016/s0140-6736(94)91810-4. [DOI] [PubMed] [Google Scholar]
  4. Bonifas J. M., Bare J. W., Kerschmann R. L., Master S. P., Epstein E. H., Jr Parental origin of chromosome 9q22.3-q31 lost in basal cell carcinomas from basal cell nevus syndrome patients. Hum Mol Genet. 1994 Mar;3(3):447–448. doi: 10.1093/hmg/3.3.447. [DOI] [PubMed] [Google Scholar]
  5. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  6. Evans D. G., Farndon P. A., Burnell L. D., Gattamaneni H. R., Birch J. M. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer. 1991 Nov;64(5):959–961. doi: 10.1038/bjc.1991.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farndon P. A., Del Mastro R. G., Evans D. G., Kilpatrick M. W. Location of gene for Gorlin syndrome. Lancet. 1992 Mar 7;339(8793):581–582. doi: 10.1016/0140-6736(92)90868-4. [DOI] [PubMed] [Google Scholar]
  8. Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986 Oct 16;323(6089):643–646. doi: 10.1038/323643a0. [DOI] [PubMed] [Google Scholar]
  9. GORLIN R. J., GOLTZ R. W. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960 May 5;262:908–912. doi: 10.1056/NEJM196005052621803. [DOI] [PubMed] [Google Scholar]
  10. Gailani M. R., Bale S. J., Leffell D. J., DiGiovanna J. J., Peck G. L., Poliak S., Drum M. A., Pastakia B., McBride O. W., Kase R. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell. 1992 Apr 3;69(1):111–117. doi: 10.1016/0092-8674(92)90122-s. [DOI] [PubMed] [Google Scholar]
  11. Goldstein A. M., Pastakia B., DiGiovanna J. J., Poliak S., Santucci S., Kase R., Bale A. E., Bale S. J. Clinical findings in two African-American families with the nevoid basal cell carcinoma syndrome (NBCC). Am J Med Genet. 1994 Apr 15;50(3):272–281. doi: 10.1002/ajmg.1320500311. [DOI] [PubMed] [Google Scholar]
  12. Gorlin R. J. Nevoid basal cell carcinoma syndrome. Dermatol Clin. 1995 Jan;13(1):113–125. [PubMed] [Google Scholar]
  13. HOWELL J. B., CARO M. R. The basal-cell nevus: its relationship to multiple cutaneous cancers and associated anomalies of development. AMA Arch Derm. 1959 Jan;79(1):67–80. doi: 10.1001/archderm.1959.01560130069008. [DOI] [PubMed] [Google Scholar]
  14. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Levanat S., Gorlin R. J., Fallet S., Johnson D. R., Fantasia J. E., Bale A. E. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet. 1996 Jan;12(1):85–87. doi: 10.1038/ng0196-85. [DOI] [PubMed] [Google Scholar]
  16. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  17. Quinn A. G., Campbell C., Healy E., Rees J. L. Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin. J Invest Dermatol. 1994 Mar;102(3):300–303. doi: 10.1111/1523-1747.ep12371786. [DOI] [PubMed] [Google Scholar]
  18. Reis A., Küster W., Linss G., Gebel E., Hamm H., Fuhrmann W., Wolff G., Groth W., Gustafson G., Kuklik M. Localisation of gene for the naevoid basal-cell carcinoma syndrome. Lancet. 1992 Mar 7;339(8793):617–617. doi: 10.1016/0140-6736(92)90903-g. [DOI] [PubMed] [Google Scholar]
  19. Report and abstracts of the 4th International Workshop on Chromosome 9. Williamsburg, Virginia, USA, April 23-25, 1995. Ann Hum Genet. 1995 Oct;59(Pt 4):347–391. [PubMed] [Google Scholar]
  20. Shanley S. M., Dawkins H., Wainwright B. J., Wicking C., Heenan P., Eldon M., Searle J., Chenevix-Trench G. Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. Hum Mol Genet. 1995 Jan;4(1):129–133. doi: 10.1093/hmg/4.1.129. [DOI] [PubMed] [Google Scholar]
  21. Springate J. E. The nevoid basal cell carcinoma syndrome. J Pediatr Surg. 1986 Oct;21(10):908–910. doi: 10.1016/s0022-3468(86)80023-9. [DOI] [PubMed] [Google Scholar]
  22. Strathdee C. A., Gavish H., Shannon W. R., Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992 Apr 30;356(6372):763–767. doi: 10.1038/356763a0. [DOI] [PubMed] [Google Scholar]
  23. Strong L. C. Genetic and environmental interactions. Cancer. 1977 Oct;40(4 Suppl):1861–1866. doi: 10.1002/1097-0142(197710)40:4+<1861::aid-cncr2820400815>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  24. Tanaka K., Miura N., Satokata I., Miyamoto I., Yoshida M. C., Satoh Y., Kondo S., Yasui A., Okayama H., Okada Y. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain. Nature. 1990 Nov 1;348(6296):73–76. doi: 10.1038/348073a0. [DOI] [PubMed] [Google Scholar]
  25. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., Tryggvason K., Reeders S. T. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science. 1993 Aug 27;261(5125):1167–1169. doi: 10.1126/science.8356449. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES